Baader Bank Aktiengesellschaft’s AbbVie ABBV Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.52M	Buy	10,017 +2,637	+36%	+$567K	0.19%	105
2026 Q1	$1.59M	Buy	7,380 +6,263	+561%	+$1.39M	0.12%	132
2025 Q4	$254K	Sell	1,117 -1,935	-63%	-$441K	0.02%	382
2025 Q3	$707K	Sell	3,052 -700	-19%	-$143K	0.05%	224
2025 Q2	$668K	Buy	3,752 +1,044	+39%	+$194K	0.05%	208
2025 Q1	$564K	Buy	2,708 +792	+41%	+$154K	0.04%	224
2024 Q4	$340K	Sell	1,916 -2,300	-55%	-$423K	0.02%	259
2024 Q3	$698K	Buy	4,216 +2,908	+222%	+$543K	0.04%	210
2024 Q2	$224K	Buy	+1,308	New	+$217K	0.01%	337
2022 Q4	–	Sell	-13,300	Closed	-$1.78M	–	357
2022 Q3	$1.78M	Hold	13,300	–	–	0.12%	162
2022 Q2	$2.04M	Sell	13,300 -74,522	-85%	-$11.4M	0.16%	135
2022 Q1	$14.2M	Hold	87,822	–	–	1.14%	19
2021 Q4	$11.9M	Buy	+87,822	New	+$10.4M	0.91%	22

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Baader Bank Aktiengesellschaft's ABBV Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft increased its AbbVie (ABBV) stake by 36% in Q2 2026, buying an estimated $567K and bringing the position to 10,017 shares worth $2.52M. The position accounts for 0.19% of the portfolio, ranked #105.

Baader Bank Aktiengesellschaft first reported a position in ABBV in Q4 2021 and has held it in 13 quarters since. The position peaked at $14.2M in Q1 2022. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Baader Bank Aktiengesellschaft held 10,017 shares of AbbVie worth $2.52M as of Q2 2026.
Baader Bank Aktiengesellschaft bought 2,637 AbbVie shares in Q2 2026, an estimated $567K.
AbbVie made up 0.19% of Baader Bank Aktiengesellschaft's portfolio in Q2 2026, its #105 holding.
Baader Bank Aktiengesellschaft first reported a position in AbbVie in Q4 2021 and has held it in 13 quarters since.
Baader Bank Aktiengesellschaft's AbbVie position peaked at $14.2M in Q1 2022.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.